tiprankstipranks
Protalix Biotherapeutics (PLX)
XASE:PLX
US Market
PLX
Protalix
RESEARCH TOOLSreports
Want to see PLX full AI Analyst Report?

Protalix (PLX) Ratios

955 Followers

Protalix Ratios

PLX's free cash flow for Q1 2026 was $0.88. For the 2026 fiscal year, PLX's free cash flow was decreased by $ and operating cash flow was $0.63. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.15 2.51 2.34 1.54 1.38
Quick Ratio
 2.04 1.54 1.52 1.12 0.87
Cash Ratio
 1.52 0.55 0.77 0.52 0.53
Solvency Ratio
 0.48 -0.15 0.14 0.19 -0.21
Operating Cash Flow Ratio
 0.55 -0.45 0.34 -0.03 -0.77
Short-Term Operating Cash Flow Coverage
 10.53 0.00 0.00 -0.06 0.00
Net Current Asset Value
$ 51.25M$ 32.56M$ 29.87M$ 19.07M$ -21.55M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.10 0.08 0.33 0.60
Debt-to-Equity Ratio
 0.13 0.17 0.13 0.82 -3.15
Debt-to-Capital Ratio
 0.11 0.15 0.11 0.45 1.47
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 1.61
Financial Leverage Ratio
 1.52 1.71 1.70 2.52 -5.24
Debt Service Coverage Ratio
 5.85 -4.22 4.99 0.51 -4.47
Interest Coverage Ratio
 12.86 -4.62 3.69 3.29 -5.15
Debt to Market Cap
 <0.01 0.00 0.00 0.18 0.42
Interest Debt Per Share
 0.13 0.12 0.09 0.46 0.74
Net Debt to EBITDA
 -1.56 1.58 -2.18 0.31 -1.52
Profitability Margins
Gross Profit Margin
69.97%47.85%54.46%64.91%58.87%
EBIT Margin
25.91%-10.43%9.77%17.93%-24.91%
EBITDA Margin
27.90%-7.65%12.21%19.75%-22.63%
Operating Profit Margin
25.91%-10.43%7.34%15.97%-27.32%
Pretax Profit Margin
25.22%-10.63%7.78%13.08%-30.22%
Net Profit Margin
20.07%-12.52%5.49%12.69%-31.33%
Continuous Operations Profit Margin
20.07%-12.52%5.49%12.69%-31.33%
Net Income Per EBT
79.58%117.76%70.58%97.03%103.68%
EBT Per EBIT
97.34%101.96%106.05%81.89%110.63%
Return on Assets (ROA)
14.98%-8.02%3.99%9.84%-26.76%
Return on Equity (ROE)
28.10%-13.69%6.79%24.76%140.29%
Return on Capital Employed (ROCE)
26.41%-9.85%8.20%26.89%-55.72%
Return on Invested Capital (ROIC)
20.62%-9.61%5.61%16.38%-53.17%
Return on Tangible Assets
14.98%-8.02%3.99%9.84%-26.76%
Earnings Yield
9.10%-4.67%2.15%6.92%-22.48%
Efficiency Ratios
Receivables Turnover
 25.99 5.97 18.36 12.42 10.39
Payables Turnover
 5.35 5.23 5.36 5.32 3.34
Inventory Turnover
 0.75 1.07 1.14 1.21 1.17
Fixed Asset Turnover
 5.90 4.19 5.33 6.02 4.94
Asset Turnover
 0.75 0.64 0.73 0.78 0.85
Working Capital Turnover Ratio
 1.54 1.41 1.81 3.55 2.33
Cash Conversion Cycle
 430.74 332.79 270.68 263.24 238.99
Days of Sales Outstanding
 14.04 61.17 19.88 29.38 35.14
Days of Inventory Outstanding
 484.87 341.39 318.83 302.47 313.06
Days of Payables Outstanding
 68.18 69.78 68.04 68.61 109.21
Operating Cycle
 498.92 402.57 338.72 331.85 348.20
Cash Flow Ratios
Operating Cash Flow Per Share
 0.19 -0.15 0.12 -0.02 -0.52
Free Cash Flow Per Share
 0.18 -0.17 0.10 -0.04 -0.53
CapEx Per Share
 <0.01 0.02 0.02 0.02 0.01
Free Cash Flow to Operating Cash Flow
 0.97 1.14 0.85 1.87 1.03
Dividend Paid and CapEx Coverage Ratio
 33.16 -7.32 6.77 -1.15 -39.81
Capital Expenditure Coverage Ratio
 33.16 -7.32 6.77 -1.15 -39.81
Operating Cash Flow Coverage Ratio
 1.78 -1.44 1.57 -0.05 -0.75
Operating Cash Flow to Sales Ratio
 0.20 -0.23 0.16 -0.02 -0.52
Free Cash Flow Yield
8.61%-9.64%5.42%-2.05%-38.59%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.36 -21.41 46.51 14.46 -4.45
Price-to-Sales (P/S) Ratio
 2.10 2.68 2.55 1.83 1.39
Price-to-Book (P/B) Ratio
 2.36 2.93 3.16 3.58 -6.24
Price-to-Free Cash Flow (P/FCF) Ratio
 10.96 -10.37 18.45 -48.71 -2.59
Price-to-Operating Cash Flow Ratio
 10.53 -11.79 15.72 -91.18 -2.66
Price-to-Earnings Growth (PEG) Ratio
 -0.01 0.07 -0.70 -0.10 0.09
Price-to-Fair Value
 2.36 2.93 3.16 3.58 -6.24
Enterprise Value Multiple
 5.96 -33.46 18.73 9.60 -7.68
Enterprise Value
 136.78M 135.02M 122.12M 124.23M 82.77M
EV to EBITDA
 6.42 -33.46 18.73 9.60 -7.68
EV to Sales
 1.79 2.56 2.29 1.90 1.74
EV to Free Cash Flow
 9.35 -9.91 16.52 -50.36 -3.23
EV to Operating Cash Flow
 9.06 -11.26 14.08 -94.26 -3.31
Tangible Book Value Per Share
 0.84 0.61 0.60 0.50 -0.22
Shareholders’ Equity Per Share
 0.84 0.61 0.60 0.50 -0.22
Tax and Other Ratios
Effective Tax Rate
 0.20 -0.18 0.29 0.03 -0.04
Revenue Per Share
 0.96 0.67 0.74 0.97 0.98
Net Income Per Share
 0.19 -0.08 0.04 0.12 -0.31
Tax Burden
 0.80 1.18 0.71 0.97 1.04
Interest Burden
 0.97 1.02 0.80 0.73 1.21
Research & Development to Revenue
 0.28 0.36 0.24 0.26 0.62
SG&A to Revenue
 0.16 0.22 0.23 0.00 -0.29
Stock-Based Compensation to Revenue
 >-0.01 0.00 0.06 0.05 0.04
Income Quality
 0.69 1.82 2.96 -0.16 1.67
Currency in USD